American Research & Management Co. United Therapeutics Corp Transaction History
American Research & Management Co.
- $362 Million
- Q3 2022
A detailed history of American Research & Management Co. transactions in United Therapeutics Corp stock. As of the latest transaction made, American Research & Management Co. holds 135 shares of UTHR stock, worth $41,990. This represents 0.01% of its overall portfolio holdings.
Number of Shares
135
Previous 135
-0.0%
Holding current value
$41,990
Previous $32,000
12.5%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding UTHR
# of Institutions
561Shares Held
43.1MCall Options Held
501KPut Options Held
529K-
Black Rock Inc. New York, NY5.57MShares$1.73 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.68MShares$1.46 Billion0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.41MShares$1.06 Billion0.14% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$889 Million7.91% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.15MShares$669 Million0.78% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $14.2B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...